SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-051972
Filing Date
2019-02-26
Accepted
2019-02-26 16:16:02
Documents
3
Period of Report
2019-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d686567d8k.htm 8-K 17130
2 EX-99.1 d686567dex991.htm EX-99.1 117537
3 GRAPHIC g686567g0226055531576.jpg GRAPHIC 2925
  Complete submission text file 0001193125-19-051972.txt   139987
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 19633590
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences